This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Apr;64(4):962-5.

doi: 10.1002/art.34362. Epub 2012 Jan 9.

The landscape after LUNAR: rituximab's crater-filled path

PMID: 22231618
DOI: 10.1002/art.34362

Editorial

The landscape after LUNAR: rituximab's crater-filled path

Liz Lightstone. Arthritis Rheum. 2012 Apr.

. 2012 Apr;64(4):962-5.

doi: 10.1002/art.34362. Epub 2012 Jan 9.

Author

PMID: 22231618
DOI: 10.1002/art.34362

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group. Rovin BH, et al. Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9. Arthritis Rheum. 2012. PMID: 22231479 Clinical Trial.

Similar articles

Rituximab, a viable alternative for induction therapy of active lupus nephritis.
Zhou XJ, Zhao MH, Zhang H. Zhou XJ, et al. Rheumatology (Oxford). 2014 Sep;53(9):1537-8. doi: 10.1093/rheumatology/keu152. Epub 2014 Apr 12. Rheumatology (Oxford). 2014. PMID: 24729446 No abstract available.
Lupus nephritis: a rituximab-based regimen might enable oral steroid avoidance in lupus nephritis.
Killock D. Killock D. Nat Rev Rheumatol. 2013 Aug;9(8):443. doi: 10.1038/nrrheum.2013.102. Epub 2013 Jun 25. Nat Rev Rheumatol. 2013. PMID: 23797310 No abstract available.
Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits.
Jónsdóttir T, Sundelin B, Welin Henriksson E, van Vollenhoven RF, Gunnarsson I. Jónsdóttir T, et al. Ann Rheum Dis. 2011 Jun;70(6):1172-3. doi: 10.1136/ard.2010.129288. Epub 2011 Mar 2. Ann Rheum Dis. 2011. PMID: 21367763 Clinical Trial. No abstract available.
New and future therapies for lupus nephritis.
Appel GB. Appel GB. Cleve Clin J Med. 2012 Feb;79(2):134-40. doi: 10.3949/ccjm.78gr.11004. Cleve Clin J Med. 2012. PMID: 22301564 Review.
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy.
Cervera R, Mosca M, Ríos-Garcés R, Espinosa G, Trujillo H, Bada T, Praga M. Cervera R, et al. Autoimmun Rev. 2019 Dec;18(12):102406. doi: 10.1016/j.autrev.2019.102406. Epub 2019 Oct 22. Autoimmun Rev. 2019. PMID: 31654743 Review. No abstract available.

See all similar articles

Cited by

Targeting the B-cell pathway in lupus nephritis: current evidence and future perspectives.
Pateinakis P, Pyrpasopoulou A. Pateinakis P, et al. ScientificWorldJournal. 2013 Sep 26;2013:745239. doi: 10.1155/2013/745239. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24191142 Free PMC article. Review.
Rationale for B cell targeting in SLE.
Sanz I. Sanz I. Semin Immunopathol. 2014 May;36(3):365-75. doi: 10.1007/s00281-014-0430-z. Epub 2014 Apr 25. Semin Immunopathol. 2014. PMID: 24763533 Free PMC article. Review.
Novel therapeutic agents in clinical development for systemic lupus erythematosus.
Jordan N, Lutalo PM, D'Cruz DP. Jordan N, et al. BMC Med. 2013 May 3;11:120. doi: 10.1186/1741-7015-11-120. BMC Med. 2013. PMID: 23642011 Free PMC article. Review.
The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.
Tsai F, Perlman H, Cuda CM. Tsai F, et al. Clin Immunol. 2017 Dec;185:74-85. doi: 10.1016/j.clim.2016.10.007. Epub 2016 Oct 22. Clin Immunol. 2017. PMID: 27780774 Free PMC article. Review.
Biologics for childhood systemic vasculitis.
Akamine K, Punaro M. Akamine K, et al. Pediatr Nephrol. 2019 Nov;34(11):2295-2309. doi: 10.1007/s00467-018-4076-2. Epub 2018 Sep 10. Pediatr Nephrol. 2019. PMID: 30203375 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley